| Analysis | Metabolite Name | Measured Value | Units | Genotype | Sex | Strain |
|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 777 | Peak area normalized | Neg | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 827 | Peak area normalized | Normal | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1004 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1009 | Peak area normalized | KO | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1012 | Peak area normalized | Neg | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1045 | Peak area normalized | KO | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1130 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1144 | Peak area normalized | WT | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1182 | Peak area normalized | Het | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1239 | Peak area normalized | Neg | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1294 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1316 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1339 | Peak area normalized | KO | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1372 | Peak area normalized | KO | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1415 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1467 | Peak area normalized | KO | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1485 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1492 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1500 | Peak area normalized | Neg | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1501 | Peak area normalized | Pos | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1505 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1517 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1558 | Peak area normalized | Neg | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1590 | Peak area normalized | WT | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1720 | Peak area normalized | KO | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1826 | Peak area normalized | KO | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1912 | Peak area normalized | Pos | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 1958 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 2024 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 2033 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 2375 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 2380 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 2589 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 2678 | Peak area normalized | Het | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 3002 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 3070 | Peak area normalized | Normal | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 3237 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 3494 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 4201 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 5038 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 5400 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 6664 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 8301 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 13726 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 24217 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 26904 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 35837 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | 52285 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | Dwarf | F | Snell | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | Dwarf | M | Snell | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | Het | F | PappA | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | Het | M | PappA | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | KO | F | GHRKO Global | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | KO | F | PappA | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | KO | M | GHRKO Global | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | KO | M | PappA | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | Neg | F | Liver GHRKO | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | Neg | M | Liver GHRKO | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | Normal | F | Snell | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | Normal | M | Snell | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | Pos | F | Liver GHRKO | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | Pos | M | Liver GHRKO | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | WT | F | GHRKO Global | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+H)+[-H2O] | Peak area normalized | WT | M | GHRKO Global | |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 1822 | Peak area normalized | Normal | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 2247 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 2578 | Peak area normalized | Normal | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 2707 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 3097 | Peak area normalized | WT | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 3255 | Peak area normalized | Normal | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 3306 | Peak area normalized | Dwarf | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 3492 | Peak area normalized | Pos | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 3686 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 3741 | Peak area normalized | Pos | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 3768 | Peak area normalized | Normal | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 3886 | Peak area normalized | Dwarf | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 3900 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 3902 | Peak area normalized | WT | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 3915 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4044 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4054 | Peak area normalized | Normal | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4072 | Peak area normalized | WT | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4093 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4107 | Peak area normalized | Het | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4112 | Peak area normalized | Normal | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4183 | Peak area normalized | Pos | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4211 | Peak area normalized | Het | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4314 | Peak area normalized | Dwarf | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4371 | Peak area normalized | WT | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4376 | Peak area normalized | Het | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4438 | Peak area normalized | Normal | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4465 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4523 | Peak area normalized | Dwarf | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4555 | Peak area normalized | Het | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4586 | Peak area normalized | Normal | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4707 | Peak area normalized | Neg | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4773 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4824 | Peak area normalized | KO | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4891 | Peak area normalized | Normal | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4910 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 4972 | Peak area normalized | Dwarf | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 5039 | Peak area normalized | Neg | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 5168 | Peak area normalized | Normal | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 5177 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 5342 | Peak area normalized | Dwarf | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 5342 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 5482 | Peak area normalized | Normal | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 5709 | Peak area normalized | Dwarf | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 5719 | Peak area normalized | Het | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 5874 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 5921 | Peak area normalized | Normal | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 6044 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 6271 | Peak area normalized | KO | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 6485 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 6521 | Peak area normalized | Pos | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 6603 | Peak area normalized | Dwarf | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 6622 | Peak area normalized | Neg | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 6652 | Peak area normalized | Dwarf | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 6760 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 6854 | Peak area normalized | Dwarf | M | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 6889 | Peak area normalized | Dwarf | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 7150 | Peak area normalized | Normal | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 7223 | Peak area normalized | Dwarf | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 7235 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 7239 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 7259 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 7454 | Peak area normalized | Neg | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 7515 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 7568 | Peak area normalized | Neg | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 7618 | Peak area normalized | Neg | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 7713 | Peak area normalized | KO | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 7949 | Peak area normalized | KO | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 8088 | Peak area normalized | KO | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 8295 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 8390 | Peak area normalized | KO | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 8439 | Peak area normalized | WT | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 8479 | Peak area normalized | KO | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 8652 | Peak area normalized | KO | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 8772 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 9109 | Peak area normalized | Dwarf | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 9183 | Peak area normalized | Pos | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 9200 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 9207 | Peak area normalized | KO | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 9274 | Peak area normalized | Het | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 9370 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 9572 | Peak area normalized | KO | M | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 9603 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 9722 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 10112 | Peak area normalized | Pos | M | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 10307 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 10387 | Peak area normalized | KO | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 10824 | Peak area normalized | Dwarf | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 11115 | Peak area normalized | KO | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 11134 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 11908 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 12376 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 12505 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 12730 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 12983 | Peak area normalized | Normal | F | Snell |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 13023 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 13871 | Peak area normalized | WT | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 14102 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 14319 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 14999 | Peak area normalized | WT | M | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 16886 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 17705 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 19174 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 24052 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 27628 | Peak area normalized | Het | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 30132 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 35378 | Peak area normalized | KO | F | PappA |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 59098 | Peak area normalized | KO | F | GHRKO Global |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 100624 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 104305 | Peak area normalized | Pos | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 148720 | Peak area normalized | Neg | F | Liver GHRKO |
| Reversed phase POSITIVE ION MODE | DIPALMITOYL-GLYCEROL (M+NA)+ | 256027 | Peak area normalized | KO | F | GHRKO Global |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|